Cholinergic dysautonomia in a patient with systemic lupus erythematosus
Rheumatology (Oxford)
.
2022 Dec 23;62(1):e9-e11.
doi: 10.1093/rheumatology/keac373.
Authors
Qi Liu
1
2
,
Yuxian Zhang
1
2
,
Hongqin Lu
1
,
Peng Yan
3
,
Xue Bai
4
,
Lili Cao
5
,
Xiuli Zuo
6
,
Chao Liu
6
,
Qiang Shu
1
2
Affiliations
1
Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University.
2
Shandong Provincial Clinical Research Center for Immune Diseases and Gout, Department of Rheumatology, Qilu Hospital, Shandong University, Jinan.
3
Department of Rheumatology, Linyi People's Hospital, Linyi.
4
Department of Radiology.
5
Department of Neurology.
6
Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
PMID:
35789378
DOI:
10.1093/rheumatology/keac373
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cholinergic Agents
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy
Primary Dysautonomias* / etiology
Substances
Cholinergic Agents